Mar Tintore Subirana I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC). Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Clinical neuroimmunology General Hospital Responsable Assistencial Multiple Sclerosis Centre of Catalonia Twitter Orcid Email Mar Tintore Subirana Twitter Orcid Email Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Clinical neuroimmunology General Hospital Responsable Assistencial Multiple Sclerosis Centre of Catalonia I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).
I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital. I have published more than 369 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until April 2026 my work has received 26,854 citations.
Projects Validación de marcadores biológicos asociados con la conversión a esclerosis múltiple en pacientes que presentan síndromes clínicos aislados IP: Manuel Comabella Lopez Collaborators: Mar Tintore Subirana Funding agency: Instituto de Salud Carlos III Funding: 134915 Reference: PI09/00788 Duration: 01/01/2010 - 30/06/2013 Estudio de marcadores biológicos pronóstico en pacientes con síndromes clínicos aislados sugestivos de esclorosis múltiple IP: Mar Tintore Subirana Collaborators: Jordi Rio Izquierdo, Rosalia Horno Ocaña, Alex Rovira Cañellas, Joaquin Castillo Justribo, Mireia Castillo Juarez, Georgina Arrambide García Funding agency: Instituto de Salud Carlos III Funding: 59229.5 Reference: PI080788 Duration: 01/01/2009 - 30/06/2012 Unitat de Neuroimmunologia Clínica (UNiC) IP: Unitat de Neuroimmunologia Clínica (UNiC) Collaborators: Susana Otero Romero, Carlos Nos Llopis, Unitat de Neuroimmunologia Clínica (UNiC), Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo , Georgina Arrambide García Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 43680 Reference: 2009 SGR 793 Duration: 01/01/2010 - 30/04/2014 Ensayo clínico, multicéntrico, con asignación aleatoria y doble ciego, para comparar la eficacia clinica y radiológica de dosis equivalentes de metilprednisolona administradas por vía oral o vía intravenosa en pacientes en brote de esclerosis múltiple. IP: Mar Tintore Subirana Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: Reference: CORTEM2007-000888-15 Duration: 01/01/2007 - 31/12/2008 Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 Next page › Last page »
